Such mix-ups, due to the similar colour of the products especially in poor lighting, can cause hypo- or hyperglycaemia. Healthcare professionals should alert patients to this risk, particularly while yellow Fiasp products are still available.
Pharmacists will receive a letter with this information and local timelines for when red and yellow Fiasp products will be introduced.